Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP

Delayed Quote. Delayed  - 04/29 09:59:57 pm
10.78 USD   -1.28%
04/20 SUCAMPO PHARMAC : Reports Top-Line Data from Phase 2a Study of Cobip..
04/20 Sucampo Announces First Quarter 2016 Earnings Call
04/19 Sucampo Reports Top-Line Data from Phase 2a Study of Cobiprostone..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
11.23(c) 11.16(c) 10.96(c) 10.92(c) 10.78(c) Last
331 268 454 963 295 079 331 344 435 414 Volume
-2.52% -0.62% -1.79% -0.36% -1.28% Change
More quotes
Financials ($)
Sales 2016 202 M
EBIT 2016 90,8 M
Net income 2016 33,8 M
Debt 2016 150 M
Yield 2016 -
Sales 2017 229 M
EBIT 2017 112 M
Net income 2017 55,2 M
Debt 2017 88,1 M
Yield 2017 -
P/E ratio 2016 14,00
P/E ratio 2017 8,69
EV / Sales 2016 3,01x
EV / Sales 2017 2,39x
Capitalization 460 M
More Financials
Company
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company which engages in research, discovery, development and commercialization of proprietary drugs in the Americas, Europe and Asia.It is developing prostones, which are ion channel activators, to treat gastrointestinal, ophthalmic and... 
More about the company
Surperformance© ratings of Sucampo Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on SUCAMPO PHARMACEUTICALS, I
04/20 SUCAMPO PHARMACEUTICALS : Reports Top-Line Data from Phase 2a Study of Cobiprost..
04/20 Sucampo Announces First Quarter 2016 Earnings Call
04/19 Sucampo Reports Top-Line Data from Phase 2a Study of Cobiprostone in Patients..
03/10 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the 28th Annu..
03/09 Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 28th Ann..
03/08 SUCAMPO PHARMACEUTICALS : tops Street 4Q forecasts
03/08 SUCAMPO PHARMACEUTICALS : Results of Operations and Financial Condition, Regulat..
03/08 Sucampo Reports Continued Strong Performance for Fourth Quarter and Full Year..
More news
Sector news : Bio Therapeutic Drugs
02:19p BRIEF : Sanofi girds for another fight
04/29 SANOFI : offers to buy Medivation for $9.3bn
04/29 SANOFI : France's Sanofi makes $9.3 billion bid for US cancer drug giant
More sector news : Bio Therapeutic Drugs
4-Traders Strategies on SUCAMPO PHARMACEUTICALS, I 
2015The bullish trend is not over
More Strategies
News from SeekingAlpha
04/26 HEDGED RELYPSA LONGS : Consider This Course Correction
04/22 Healthcare ratings roundup
04/19 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
04/19 Sucampo Pharma's cobiprostone flunks mid-stage reflux disease study; shares o..
03/21 An Analysis Of The iShares Micro-Cap ETF


Comments 
Advertisement
Chart SUCAMPO PHARMACEUTICALS, I
Duration : Period :
Sucampo Pharmaceuticals, I Technical Analysis Chart | SCMP | US8649091068 | 4-Traders
Full-screen chart
Technical analysis trends SUCAMPO PHARMACEU...
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions